Agouron ready to ship Viracept

The FDA on Friday gave its blessing to Viracept HIV protease inhibitor - less than three months after Agouron Pharmaceuticals Inc. filed its NDA - clearing the way for AGPH to put the drug on pharmacy shelves as soon as this week.

CEO Peter Johnson said the company expects to ship 21,000

Read the full 515 word article

How to gain access

Continue reading with a
two-week free trial.